Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)

Alexander Egeberg; Jacob P Thyssen

doi:10.1093/bjd/ljad039

Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)

Dermatologisk og Venerologisk Afdeling og Videncenter for Sårheling BFH

18 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	British Journal of Dermatology
Vol/bind	188
Udgave nummer	6
Sider (fra-til)	793-794
Antal sider	2
ISSN	0007-0963
DOI	https://doi.org/10.1093/bjd/ljad039
Status	Udgivet - 24 maj 2023

Adgang til dokumentet

10.1093/bjd/ljad039

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{86a3d4f93093420e83fc68cbda5e45eb,

title = "Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)",

keywords = "United States, Humans, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Product Surveillance, Postmarketing, Stroke/chemically induced, Drug-Related Side Effects and Adverse Reactions",

author = "Alexander Egeberg and Thyssen, \{Jacob P\}",

year = "2023",

month = may,

day = "24",

doi = "10.1093/bjd/ljad039",

language = "English",

volume = "188",

pages = "793--794",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)

AU - Egeberg, Alexander

AU - Thyssen, Jacob P

PY - 2023/5/24

Y1 - 2023/5/24

KW - United States

KW - Humans

KW - United States Food and Drug Administration

KW - Adverse Drug Reaction Reporting Systems

KW - Product Surveillance, Postmarketing

KW - Stroke/chemically induced

KW - Drug-Related Side Effects and Adverse Reactions

UR - https://www.scopus.com/pages/publications/85156193618

U2 - 10.1093/bjd/ljad039

DO - 10.1093/bjd/ljad039

M3 - Journal article

C2 - 36797979

SN - 0007-0963

VL - 188

SP - 793

EP - 794

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 6

ER -